Trial Profile
A Phase 1 Bioavailability Study of Arbaclofen Placarbil Modified Release Formulations in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Arbaclofen placarbil (Primary)
- Indications Alcoholism
- Focus Pharmacokinetics
- Sponsors Indivior
- 28 Jul 2017 Status changed from recruiting to completed.
- 22 Feb 2017 New trial record